THESEUS PHARMACEUTICALS, INC. Earnings Per Share (Diluted)
THESEUS PHARMACEUTICALS, INC. reported Earnings Per Share (Diluted) of -$0.31 per share for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2023-11-17
- THESEUS PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2023-09-30 was -$0.31.
- THESEUS PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2023-06-30 was -$0.34.
- THESEUS PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2023-03-31 was -$0.34.
- THESEUS PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2022-12-31 was -$0.35.
- THESEUS PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2022 was -$1.31.
- THESEUS PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2021 was -$2.84.
- THESEUS PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2020 was -$21.10.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$0.31 10-Q · filed 2023-11-17 | -$0.65 derived: net income ÷ weighted average shares · filed 2023-11-17 | -$0.99 10-Q · filed 2023-11-17 | -$1.34 derived: net income ÷ weighted average shares · filed 2023-11-17 |
| 2023-06-30 | -$0.34 10-Q · filed 2023-08-10 | -$0.68 10-Q · filed 2023-08-10 | -$1.04 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$1.42 derived: net income ÷ weighted average shares · filed 2023-11-17 |
| 2023-03-31 | -$0.34 10-Q · filed 2023-05-11 | -$0.70 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$1.08 derived: net income ÷ weighted average shares · filed 2023-11-17 | -$1.38 derived: net income ÷ weighted average shares · filed 2023-11-17 |
| 2022-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.74 derived: net income ÷ weighted average shares · filed 2023-11-17 | -$1.04 derived: net income ÷ weighted average shares · filed 2023-11-17 | -$1.31 10-K · filed 2023-03-09 |
| 2022-09-30 | -$0.38 10-Q · filed 2023-11-17 | -$0.69 derived: net income ÷ weighted average shares · filed 2023-11-17 | -$0.96 10-Q · filed 2023-11-17 | -$1.21 derived: net income ÷ weighted average shares · filed 2023-11-17 |
| 2022-06-30 | -$0.30 10-Q · filed 2023-08-10 | -$0.58 10-Q · filed 2023-08-10 | -$0.82 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$1.34 derived: net income ÷ weighted average shares · filed 2023-08-10 |
| 2022-03-31 | -$0.27 10-Q · filed 2023-05-11 | -$0.52 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$1.06 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$1.75 derived: net income ÷ weighted average shares · filed 2023-05-11 |
| 2021-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.87 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.80 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$2.84 10-K · filed 2023-03-09 |
| 2021-09-30 | -$5.16 10-Q · filed 2022-11-03 | -$11.69 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$18.69 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$6.82 10-Q · filed 2022-08-11 | -$11.81 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | -$4.90 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$21.10 10-K · filed 2022-03-10 |